New thematic analysis by Times Higher Education reveals the institutions that are walking the talk on sustainability. Over in Asia, CUHK’s ranks joint eighth for outreach.

CUHK’s Faculty of Medicine has identified a new surgery technique that was better at preventing bladder cancer from recurring in patients compared with traditional procedures.

A research team from CUHK has developed a mobile app to help users assess depression through AI analysis of facial expressions, voice and language.

A CUHK research team has developed a 3D-printable bioactive material for the repair of severe tears of the shoulder tendons, also known as the rotator cuff.

A team of paleontologists, including scholar from CUHK, has identified a new species of abelisauroid dinosaur. They have named it Koleken inakayali. The work is published in the journal Cladistics.

CUHK researchers find increasing activity time among calligraphers has positive effects on brain networks.

A CUHK-Elsevier report shows that research output in the Greater Bay Area (GBA) has almost doubled in five years, with Hong Kong contributing 28% and driving the region’s research.

A research team from CUHK’s Faculty of Medicine has developed a cutting-edge computational model, beth-1, which works like a weather forecast to project virus changes in the future for optimal vaccine strain selection.

CUHK has employed an artificial intelligence (AI) chatbot to provide mental health support to the city’s youth amid increasing demand for services and the growing complexity of cases.

A CUHK study suggests that adopting a healthy lifestyle, including physical activity, quality diet, adequate sleep, moderate alcohol intake and not smoking, can reduce the risk of developing irritable bowel syndrome (IBS).

A joint multi-disciplinary team from CUHK and The University of Hong Kong has developed an interactive robotic positioner for neurosurgery, aiming to provide more accurate and effective treatment for brain tumors and Parkinson’s disease.

A CUHK research team has identified a new therapeutic target for lung cancer by targeting the Macrophage-Myofibroblast Transition (MMT) process regulated by the blood formation regulator Runx1.